Deferred Tax Assets, Valuation Allowance of Voyager Therapeutics, Inc. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Voyager Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • Voyager Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $145,426,000, a 37% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Voyager Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $145,426,000 +$39,572,000 +37% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q4 2024 $105,854,000 +$23,242,000 +28% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q4 2023 $82,612,000 -$34,804,000 -30% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q4 2022 $117,416,000 +$9,853,000 +9.2% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q4 2021 $107,563,000 +$22,697,000 +27% 31 Dec 2021 10-K 07 Mar 2023 2022 FY
Q4 2020 $84,866,000 -$34,000 -0.04% 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q4 2019 $84,900,000 -$6,000,000 -6.6% 31 Dec 2019 10-K 08 Mar 2022 2021 FY
Q4 2018 $90,900,000 +$45,947,000 +102% 31 Dec 2018 10-K 25 Feb 2021 2020 FY
Q4 2017 $44,953,000 +$13,592,000 +43% 31 Dec 2017 10-K 26 Feb 2019 2018 FY
Q4 2016 $31,361,000 +$16,154,000 +106% 31 Dec 2016 10-K 14 Mar 2018 2017 FY
Q4 2015 $15,207,000 +$7,608,000 +100% 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q4 2014 $7,599,000 31 Dec 2014 10-K 17 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.